SCHEMBL6983354

SCHEMBL6983354

Nc1nc(N)nc(-c2cncc(Br)c2)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTK2 Q05397 1/20 0.49
CYP11B2 P19099 3/20 0.42
POLB P06746 2/20 0.42
ADORA3 P0DMS8 1/20 0.42
ADORA2A P29274 1/20 0.42
ADORA2B P29275 1/20 0.42
ADORA1 P30542 1/20 0.42
CYP2A6 P11509 2/20 0.42
RAB9A P51151 4/20 0.40
NPC1 O15118 3/20 0.40
KDM4E B2RXH2 3/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
HCAR2 Q8TDS4 1/20 0.38
CYP11B1 P15538 2/20 0.37
PDPK1 O15530 1/20 0.36
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HDAC6 Q9UBN7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10498616 0.76 PTK2 (0.49) PTK2CYP11B2POLBCYP2A6RAB9A
SCHEMBL14392676 0.75 CYP2A6 (0.61) PTK2CYP11B2POLBCYP2A6RAB9A
SCHEMBL18253593 0.74 CYP11B2 (0.48) PTK2CYP11B2POLBADORA3ADORA2A
SCHEMBL9566571 0.72 RAB9A (0.61) POLBADORA3ADORA2AADORA2BADORA1
SCHEMBL29856016 0.72 CYP11B2 (0.43) PTK2CYP11B2POLBCYP2A6RAB9A
SCHEMBL20839258 0.72 CYP11B2 (0.43) PTK2CYP11B2POLBCYP2A6RAB9A
SCHEMBL27987495 0.72 KDM4E (0.49) CYP11B2POLBADORA3ADORA2AADORA2B
SCHEMBL28814830 0.72 ADORA3 (0.50) POLBADORA3ADORA2AADORA2BADORA1
SCHEMBL5799279 0.71 PTK2 (0.52) PTK2CYP11B2POLBCYP2A6RAB9A
SCHEMBL27736014 0.71 PDPK1 (0.41) PTK2CYP11B2POLBADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US claimed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP claimed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO claimed
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP disclosed
US-6288228-B1 DIAMINOTRIAZINE DERIVATIVES ABBOTT LABORATORIES 2001-09-11 US disclosed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US disclosed